Biopolymer Shared Service
生物聚合物共享服务
基本信息
- 批准号:7696605
- 负责人:
- 金额:$ 5.32万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2008
- 资助国家:美国
- 起止时间:2008-08-08 至 2011-07-31
- 项目状态:已结题
- 来源:
- 关键词:AccountingAntisense OligonucleotidesArtsBiopolymersBlood capillariesCalibrationCancer CenterCommitComplexComputers and Advanced InstrumentationCyclic PeptidesDNADevelopmentEffectivenessEnvironmentFacultyFluorescence Resonance Energy TransferFosteringFundingGene ExpressionGenomeGenotypeGrantHourInstitutesInvestigationLabelMalignant NeoplasmsMarylandMeasurableMethodologyMissionMolecularMolecular ProbesMutationNational Cancer InstituteNumbersOligonucleotidesPeptide SynthesisPeptidesPharmaceutical PreparationsPolymersPublicationsRNA chemical synthesisReference StandardsResearchResearch PersonnelResourcesScienceServicesStandards of Weights and MeasuresStudentsSystemTechnologyTimeTrainingUniversitiesValidationbasecapillarycostfallsgenome wide association studyinnovative technologiesinstrumentinstrumentationmedical specialtiesmembernext generationnovelprogramssuccesssynthetic peptide
项目摘要
Biopolymer Shared Service
The Biopolymer Shared Service (SS) uses state-of-the-art instrumentation to support molecular biologybased
research through services that include DNA/RNA synthesis, DMA sequencing, genotyping, and
peptide synthesis. The facility provides these services to the entire University of Maryland campus. The
University of Maryland Marlene and Stewart Greenebaum Cancer Center's (UMGCC's) membership
accounts for about one fourth of the facility's use.
The Biopolymer SS synthesizes oligonucleotides with a rapid 24-hour turnaround time. The facility also
routinely synthesizes specialty oligonucleotides, such as SiRNA, and dual-labeled fluorescence resonance
energy transfer probes, molecular beacons, and antisense oligonucleotides in a rapid, cost-effective
manner. The addition of a 96-capillary array DNA sequencer (ABI 3730XL) to the facility has greatly
enhanced this service, decreasing chargeback costs and turnaround time and increasing throughput. An
Affymetrix GeneChip System 3000 7G supports microarray-based expression and genome-wide association
studies. The use of synthetic peptides in this research environment has expanded through the facility's
ability to provide modified peptides, such as cyclic peptides, via multiple methodologies, labeled peptides,
and complex multibranched polymers. The Biopolymer SS will incorporate an Illumina (formerly Solexa)
Genome Analyzer in fall 2007, with significant support from UMGCC. This next-generation sequencer will
enhance the capabilities to detect novel, cancer-associated mutations and provide a unique platform for
determining changes in gene expression.
Additionally, the Biopolymer SS embodies an intellectual reservoir for the development of innovative
technology. The facility's partnership with investigators greatly enhances its research programs. The shared
service has also developed novel peptide standards in conjunction with the National Institute of Standards
and Technology; these will serve as standard reference material for drug validation and instrument
calibration. The facility has received competitive shared instrumentation grants, allowing it to provide highly
effective support of cutting-edge research with state-of-the-art instrumentation. This effectiveness is
measurable by the large number of publications that the facility has supported: more than 100 publications
per year from members of UMGCC alone. Many of these publications focus on investigations funded by the
National Cancer Institute.
生物聚合物共享服务
生物聚合物共享服务(SS)使用最先进的仪器来支持基于分子生物学的仪器
通过包括DNA/RNA合成,DMA测序,基因分型和
肽合成。该设施为整个马里兰大学校园提供了这些服务。这
马里兰州玛琳大学和斯图尔特·格林鲍姆癌症中心(UMGCC)会员资格
约占该设施使用的四分之一。
生物聚合物SS以24小时的周转时间快速合成寡核苷酸。设施也是如此
常规合成特种寡核苷酸,例如siRNA和双标记的荧光共振
能量转移探针,分子信标和反义寡核苷酸快速,成本效益
方式。将96个毛细管阵列DNA Sequencer(ABI 3730xl)添加到该设施中
增强了这项服务,降低了退款成本和周转时间以及增加的吞吐量。一个
Affymetrix Genechip System 3000 7G支持基于微阵列的表达和全基因组关联
研究。在该研究环境中的合成肽的使用已通过该设施的
能够通过多种方法,标记的肽,提供改良的肽,例如环状肽,
和复杂的多型聚合物。生物聚合物SS将结合一个Illumina(以前为Solexa)
2007年秋季的基因组分析仪,在UMGCC的大力支持下。下一代的音序器将
增强检测新颖的,与癌症相关的突变的能力,并为
确定基因表达的变化。
此外,生物聚合物SS体现了创新发展的知识分子库
技术。该设施与研究人员的合作关系大大增强了其研究计划。共享
服务还与国家标准研究所共同开发了新颖的肽标准
和技术;这些将用作药物验证和仪器的标准参考材料
校准。该设施已获得有竞争力的共享仪器赠款,使其能够高度提供
最先进的仪器对尖端研究的有效支持。这种有效性是
该设施支持的大量出版物可衡量:100多个出版物
仅UMGCC成员每年。这些出版物中的许多侧重于由
国家癌症研究所。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Nicholas P Ambulos其他文献
Nicholas P Ambulos的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Nicholas P Ambulos', 18)}}的其他基金
相似国自然基金
头颈鳞癌中SETD1A反义寡核苷酸触发dsRNA/RIG-I/IFN信号和细胞焦亡诱导TAMs向M1极化的机制研究
- 批准号:82303133
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
反义寡核苷酸—核酸适配体嵌合体的靶向分子设计与催化降解机理研究
- 批准号:22307124
- 批准年份:2023
- 资助金额:30.00 万元
- 项目类别:青年科学基金项目
反义寡核苷酸诱导一种新型RNA编辑的研究
- 批准号:32271346
- 批准年份:2022
- 资助金额:54 万元
- 项目类别:面上项目
载反义寡核苷酸超声微泡靶向α-突触核蛋白改善帕金森病病理的实验研究
- 批准号:
- 批准年份:2022
- 资助金额:30 万元
- 项目类别:青年科学基金项目
载反义寡核苷酸超声微泡靶向α-突触核蛋白改善帕金森病病理的实验研究
- 批准号:82201408
- 批准年份:2022
- 资助金额:30.00 万元
- 项目类别:青年科学基金项目
相似海外基金
The Mammalian Cellular Splicing Machine - Structure and Function
哺乳动物细胞拼接机 - 结构和功能
- 批准号:
7807999 - 财政年份:2008
- 资助金额:
$ 5.32万 - 项目类别:
The Mammalian Cellular Splicing Machine - Structure and Function
哺乳动物细胞拼接机 - 结构和功能
- 批准号:
7615741 - 财政年份:2008
- 资助金额:
$ 5.32万 - 项目类别:
The Mammalian Cellular Splicing Machine - Structure and Function
哺乳动物细胞拼接机 - 结构和功能
- 批准号:
7621238 - 财政年份:2008
- 资助金额:
$ 5.32万 - 项目类别: